News
HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...
A study led by Harvard Medical School, explored the reason that causes the rise of aortic aneurysms, thus offering vital ...
14hon MSN
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...
The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable. This new drug promises better adherence and wider access, especially in ...
17h
NDTV Profit on MSN‘Peace through strength’, Trump’s leadership created pivot of history: NetanyahuIsraeli PM Benjamin Netanyahu praises US President Donald Trump for striking Iran's nuclear facilities, foreseeing a future ...
President Trump announces US airstrikes on Iran's nuclear sites Fordow, Natanz, and Isfahan, marking a direct intervention in ...
Sarah Kasadha, the Deputy Resident District Commissioner (RDC), criticized the growing trend as a sign of declining ...
Speaking at a two-day training retreat at the Source of the Nile Hotel, Dr. Egessa Simplicious, Public Relations Officer at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results